Authors
Latest:
Advancement in TED treatment is a bright spotFDA approval of teprotumumab as therapeutic offers hope for patients.
Latest:
Protecting cataract patients and their surgeons' practicesMaximizing refractive surgery is key to ensuring prosperous future
Latest:
IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linkingJohn D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
Latest:
ARVO 2024: Repeatability and reproducibility of FLIO and erythrocyte mediated angiography in a non-human primate modelIn a conversation with the Eye Care Network at ARVO, Osamah Saeedi, MD, MS, Associate Professor of Ophthalmology, Director of Clinical Research and Director of the Glaucoma Division at the University of Maryland School of Medicine, explained the key findings from his poster.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Managing neovascular retinal disease in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key.
Latest:
Final Pearls on Managing Dry Eye Patients With ComorbiditiesOphthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Focusing on postinjection endophthalmitisSystemic immunosuppression may prevent devastating complication in patients.
Latest:
Seize underutilized opportunity to treat glaucoma during vitrectomyOphthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Latest:
Benefits of topography-guided treatments for irregular corneasProcedure can improve best-corrected visual acuity, enhancing quality of life for patients.
Latest:
The evolving role of vitreosurgical simulators in surgical trainingNeed to eliminate errors results in optimization of training of novice surgeons.
Latest:
Considerations for the Future of Biosimilars in the Treatment of Retinal DisordersCarl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Latest:
Weighing treatments for chronic postop cystoid macular edemaPrompt and adequate action is a key to facilitating the best recovery in patients.
Latest:
FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasisOcuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
Latest:
Increasing your practice’s reach, relevance, and revenue with clinical trialsWorking as an investigator can prove to be a positive experience for physicians
Latest:
The eyes offer conjunctival clue to COVID-19A patient's vision loss leads to another diagnosis
Latest:
CIME 2024: Neda Shamie, MD, recaps a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussionThe 18th annual Controversies in Modern Eye Care conference, held on May 4, 2024, in Los Angeles, was co-chaired by Neda Shamie, MD, and Arjan Hura, MD, with the aim of discussing the latest advancements in eye care.
Latest:
Patient case 2: DME Patient Treated with Ranibizumab BiosimilarDilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Latest:
Future Directions of Retinal Eye DisordersDilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss future directions and unmet needs in the field of retinal eye disease.
Latest:
Driving practice growth: Expand on link between dry eye, aestheticsOne obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Latest:
Ophthalmologists embrace potential of clinically tested nutraceuticals for dry eye diseaseLook beyond isolated treatment of the eye to address systemic factors.
Latest:
Protection of eyes during prone positioning must be routinely monitored in ICUTreatment of patients with COVID-19 should include ophthalmic considerations.
Latest:
VLOG: Neuro-Ophthalmology interprofessional eConsultsAndrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance
